Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia
Results
Phase 3
This trial compared the at the time to ibrutinib alone or with rituximab or venetoclax, for chronic lymphocytic leukaemia. It was for people who hadn’t had treatment yet.
The trial was supported by Cancer Research UK. It was open for people to join between 2014 and 2024. The team published results in several medical journals between 2021 and 2024. They plan to publish more in the future.
Recruitment start: 21 August 2014
Recruitment end: 19 January 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Talha Munir
Cancer Research UK
Abbvie
Janssen Pharmaceuticals
University of Leeds
This is Cancer Research UK trial number CRUK/12/037.
Last reviewed: 17 Oct 2025
CRUK internal database number: 10515
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
